Cargando…
Point-of-care assays can detect COVID-19 antibodies via serum or whole blood
Autores principales: | Schuler, Charles, Baldwin, James, Baker, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849427/ http://dx.doi.org/10.1016/j.jaci.2020.12.296 |
Ejemplares similares
-
Does Point-Of-Care SARS-CoV-2 Antibody Testing Have Similar Sensitivity and Specificity To High Complexity Serology?
por: O'Shea, Kelly, et al.
Publicado: (2021) -
Spike Antibody Assays Can Screen For Viral Neutralizing Activity Toward SARS-CoV-2
por: Schuler, Charles, et al.
Publicado: (2022) -
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
por: Inchiosa, Mario A., et al.
Publicado: (2012) -
Accurate point-of-care serology tests for COVID-19
por: Schuler, Charles F., et al.
Publicado: (2021) -
Development of a new monoclonal antibody-based point-of-care testing assay for the quantification of procalcitonin in whole blood for a rapid sepsis diagnostic
por: Rieger, Martin, et al.
Publicado: (2013)